Name | Zosuquidar trihydrochloride |
---|---|
Supplier | Tocris Bioscience |
Catalog | 1094 |
Prices | $185.00, $755.00 |
Sizes | 10 mg, 50 mg |
Function Type | Inhibitor |
Cas Number | 167465-36-3 |
Chemical Name | (αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanoltrihydrochloride |
Formula | C32H31F2N3O2.3HCl |
Molecular Weight | 636.99 |
Purity | >98 % |
Description | High affinity P-glycoprotein (P-gp) inhibitor (K d = 79 nM). Restores doxorubicin (Cat. No. 2252) sensitivity in P-gp-expressing multidrug (MDR) resistant cancer cell lines. Also potentiates antitumor efficacy of taxol (Cat. No. 1097) in a MDR human non-small cell lung carcinoma xenograft mouse model. |
Supplier Page | Shop |
Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM, Bumol TF, Starling JJ. Cancer Res. 1996 Sep 15;56(18):4171-9.
Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS, Binkley SN, Kuhfeld MT, Starling JJ, Wrighton SA. J Pharmacol Exp Ther. 1999 Aug;290(2):854-62.